Category: Prescription Drugs
Global Prescription Drugs
-
Morphine Drugs Market Size, Trends, Analysis, and Outlook By Product (Immediate Release/ Short Acting Opioids (Codeine, Oxycodone, Hydrocodone, Fentanyl, Morphine, Hydroxymorphone, Oxymorphone, Propoxyphene, Others), Extended Release/Long Acting Opioids (Oxycodone, Hydrocodone, Methadone, Fentanyl, Morphine, Oxymorphone, Tapentadol, Buprenorphine, Hydromorphone, Others)), By Application (Pain Relief (Cancer Pain, Post-Operative Care, Lower Back Pain, Orthopedic, Neuropathic, Fibromyalgia), Anesthesia, Cough Suppression, Diarrhoea Suppression, De-addiction), by Region, Country, Segment, and Companies, 2024-2030
... Buprenorphine, Hydromorphone, Others)), By Application (Pain Relief (Cancer Pain, Post-Operative Care, Lower Back Pain, Orthopedic, Neuropathic, Fibromyalgia), Anesthesia, Cough Suppression, Diarrhoea Suppression, De-addiction), by Region, Country, Segment, and Companies, 2024-2030 The global Morphine Drugs market ... Read More
-
Global Genitourinary Drugs Market Growth 2024-2030
... Genitourinary Drugs is forecast to a readjusted size of US$ 35310 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Genitourinary Drugs market. ... Read More
-
Smoking Cessation and Nicotine De-Addiction Market Size, Trends, Analysis, and Outlook By Nicotine Replacement Therapy (Nicotine Spray, Nicotine Inhalers, Nicotine Gum, Nicotine Transdermal Patches, Nicotine Sublingual Tablets, Nicotine Lozenges), By Drug Therapy (Varenicline, Zyban, Nicorette Buccal, E-cigarettes/E-liquid), by Region, Country, Segment, and Companies, 2024-2030
... Buccal, E-cigarettes/E-liquid), by Region, Country, Segment, and Companies, 2024-2030 The global Smoking Cessation and Nicotine De-Addiction market size is poised to register 10% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Antibiotics Market Size, Trends, Analysis, and Outlook By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, Others), By Type (Branded Antibiotics, Generic Antibiotics), By Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Region, Country, Segment, and Companies, 2024-2030
... Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antibiotics market size is poised to register 4.79% growth from 2024 to 2030, presenting significant growth prospects ... Read More
-
Vulvovaginal Candidiasis Treatment Market Size, Trends, Analysis, and Outlook By Drug Class (Clotrimazole, Nystatin, Fluconazole, Ketoconazole, Terbinafine, Terconazole, Others), By Route of Administration (Oral, Intravenous, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Vulvovaginal Candidiasis Treatment market size is poised to register 4.66% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Influenza Medications Market Size, Trends, Analysis, and Outlook By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Distribution Channel ( Hospital Pharmacy, Independent Pharmacy and Drug Store, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... The global Influenza Medications market size is poised to register 5.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Influenza Medications market ... Read More
-
Ophthalmic Drugs Market Size, Trends, Analysis, and Outlook By Class (Anti-allergy, Steroidal drugs, Anti-VEGF Agents, Anti-glaucoma, Others), By Disease (Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, Uveitis, Others), By Dosage Form (Gels, Eye, Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments, Others), By Route of Administration (Topical, Local Ocular(Retinal Disorders, Subconjunctival, Intravitreal, Retrobulbar, Intracameral), Systemic), By Dosage Type (Gels, Eye Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments), By Product Type (Prescription Drugs, OTC Drugs), By Product (Branded Drugs, Generic Drugs), by Region, Country, Segment, and Companies, 2024-2030
... Suspensions, Capsules and Tablets, Eye Drops, Ointments, Others), By Route of Administration (Topical, Local Ocular(Retinal Disorders, Subconjunctival, Intravitreal, Retrobulbar, Intracameral), Systemic), By Dosage Type (Gels, Eye Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments), ... Read More
-
Automated Dispensing Machines Market Size, Trends, Analysis, and Outlook By Application (Outpatient, Inpatient), By End-User (Hospitals, Retail Drug Stores and Pharmacies), By Operation (Centralized Pharmacies, Decentralized Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... global Automated Dispensing Machines market size is poised to register 8.47% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Automated Dispensing Machines ... Read More
-
Botanicals and Acupuncture Market Size, Trends, Analysis, and Outlook By Intervention (Acupuncture, Ayurveda, Naturopathy, Homeopathy), By Application (Prescription, Over the Counter), By Distribution Channel (E-sales, Distance Correspondence, Direct Sales), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Botanicals and Acupuncture market size is poised to register 16.38% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Botanicals ... Read More
-
Antiviral Drugs Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Class, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antiviral Drugs market size is poised to register 4.55% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Pulmonary Arterial Hypertension Market Size, Trends, Analysis, and Outlook By Class (Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors. Prostacyclin and Prostacyclin Analogs, SGC Stimulators), By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Pulmonary Arterial Hypertension market size is poised to register 5.93% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Global Hospital Acquired Pneumonia Drugs Market Growth 2024-2030
... in downstream market, the Hospital Acquired Pneumonia Drugs is forecast to a readjusted size of US$ 3059.9 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential ... Read More
-
The 2025-2030 World Outlook for Air Cargo Narcotics Detection Screening Systems
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Human Insulin Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Bacterial Conjunctivitis Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Dermatitis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Subcutaneous Immunoglobin
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Peripheral Neuropathy Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Herpes Simplex Virus Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Mood Stabilizers for Bipolar Disorders
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Diabetes Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Hospital Pharmaceuticals
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Plantar Fasciitis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Cholesterol-Lowering Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Cholestrol Lowering Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
